Imaging in drug development
Affiliations
- PMID: 16163191
Item in Clipboard
Imaging in drug development
Clin Adv Hematol Oncol.
2004 May.
No abstract available
Similar articles
-
Monitoring responses to antiangiogenic agents using noninvasive imaging tests.Cancer J Sci Am. 1999 Sep-Oct;5(5):252-6. Cancer J Sci Am. 1999. PMID: 10526663 Review. No abstract available.
-
A review: Integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesis.Nanomedicine. 2005 Jun;1(2):110-4. doi: 10.1016/j.nano.2005.03.008. Nanomedicine. 2005. PMID: 17292065 Review. No abstract available.
-
Antivascular cancer treatments: imaging biomarkers in pharmaceutical drug development.Br J Radiol. 2003;76 Spec No 1:S83-6. doi: 10.1259/bjr/15255885. Br J Radiol. 2003. PMID: 15456717 Review. No abstract available.
-
Biomarkers of angiogenesis and their role in the development of VEGF inhibitors.Br J Cancer. 2010 Jan 5;102(1):8-18. doi: 10.1038/sj.bjc.6605483. Epub 2009 Dec 15. Br J Cancer. 2010. PMID: 20010945 Free PMC article. Review.
-
Can contrast-enhanced US with targeted microbubbles monitor the response to antiangiogenic therapies?Radiology. 2008 Feb;246(2):339-40. doi: 10.1148/radiol.2462071720. Radiology. 2008. PMID: 18227533 No abstract available.
Cited by
-
[Current status and future direction of multi-targeted drugs in the era of personalized therapy--overview of advances in multi-targeted therapy in non-small cell lung cancer].Zhongguo Fei Ai Za Zhi. 2011 Nov;14(11):874-9. doi: 10.3779/j.issn.1009-3419.2011.11.08. Zhongguo Fei Ai Za Zhi. 2011. PMID: 22104223 Free PMC article. Review. Chinese.
-
Multi-targeted tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: an era of individualized therapy.Transl Lung Cancer Res. 2012 Mar;1(1):72-7. doi: 10.3978/j.issn.2218-6751.2011.12.04. Transl Lung Cancer Res. 2012. PMID: 25806157 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical